RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer.
Engebraaten O, Yau C, Berg K, Borgen E, Garred Ø, Berstad MEB, Fremstedal ASV, DeMichele A, Veer LV', Esserman L, Weyergang A.
Engebraaten O, et al. Among authors: berstad meb.
Nat Commun. 2021 Nov 5;12(1):6427. doi: 10.1038/s41467-021-26018-z.
Nat Commun. 2021.
PMID: 34741021
Free PMC article.